cyc 202 has been researched along with meridianin a in 1 studies
Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (meridianin a) | Trials (meridianin a) | Recent Studies (post-2010) (meridianin a) |
---|---|---|---|---|---|
979 | 7 | 393 | 11 | 0 | 10 |
Protein | Taxonomy | cyc 202 (IC50) | meridianin a (IC50) |
---|---|---|---|
3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | 5.4 | |
Cyclin-T1 | Homo sapiens (human) | 2.4 | |
G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 2.5 | |
cGMP-dependent protein kinase 1 | Bos taurus (cattle) | 2.2667 | |
cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 2.2667 | |
Cyclin-dependent kinase 1 | Homo sapiens (human) | 2.36 | |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 2.325 | |
Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | 2.2667 | |
Cyclin-A2 | Homo sapiens (human) | 3.1 | |
Cyclin-dependent kinase 2 | Homo sapiens (human) | 3.1 | |
Glycogen synthase kinase-3 beta | Homo sapiens (human) | 1.3 | |
Cyclin-dependent kinase 9 | Homo sapiens (human) | 2.4 | |
Cyclin-A1 | Homo sapiens (human) | 3.1 | |
Casein kinase I isoform alpha | Rattus norvegicus (Norway rat) | 2.2667 | |
Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 2.66 | |
Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 2.45 | |
G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 2.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Kier Joffe, EB; Franco, LH; Gompel, M; Leost, M; Meijer, L; Palermo, J; Puricelli, L | 1 |
1 other study(ies) available for cyc 202 and meridianin a
Article | Year |
---|---|
Meridianins, a new family of protein kinase inhibitors isolated from the ascidian Aplidium meridianum.
Topics: Aminopyridines; Animals; Cell Division; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indole Alkaloids; Mice; Protein Kinase Inhibitors; Urochordata | 2004 |